1887

Abstract

Outbreaks or clusters of community-acquired meticillin-resistant (CA-MRSA) within families have been reported. We describe a family cluster of CA-MRSA skin and soft-tissue infection where CA-MRSA was suspected because of recurrent infections which failed to respond to flucloxacillin. While the prevalence of CA-MRSA is low worldwide, CA-MRSA should be considered in certain circumstances depending on clinical presentation and risk assessment. Surveillance cultures of family contacts of patients with MRSA should be considered to help establish the prevalence of CA-MRSA and to inform the optimal choice of empiric antibiotic treatment.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.015925-0
2010-04-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/4/489.html?itemId=/content/journal/jmm/10.1099/jmm.0.015925-0&mimeType=html&fmt=ahah

References

  1. Adhikari, R. P., Cook, G. M., Lamont, I., Lang, S., Heffernan,H. & Smith, J. M. ( 2002; ). Phenotypic and molecularcharacterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 50, 825–831.[CrossRef]
    [Google Scholar]
  2. CLSI ( 2007; ). Performance Standardsfor Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement.CLSI Document M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. CLSI ( 2009; ). Performance Standardsfor Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement.CLSI Document M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
  4. Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber,M. J., Karchmer, A. W. & Carmeli, Y. ( 2003; ). Comparisonof mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin InfectDis 36, 53–59.
    [Google Scholar]
  5. Davis, K. A., Stewart, J. J., Crouch, H. K., Florez, C. E. &Hospenthal, D. R. ( 2004; ). Methicillin-resistant Staphylococcus aureus (MRSA) nares colonisation at hospitaladmission and its effect on subsequent MRSA infection. Clin InfectDis 39, 776–782.
    [Google Scholar]
  6. Deurenberg, R. H. & Stobberingh, E. E. ( 2009; ). The molecular evolution of hospital- and community-associatedmethicillin-resistant Staphylococcus aureus. Curr MolMed 9, 100–115.
    [Google Scholar]
  7. Diep, B. A., Palazzolo-Ballance, A. M., Tattevin, P., Basuino,L., Braughton, K. R., Whitney, A. R., Chen, L., Kreiswirth, B. N., Otto, M. &other authors ( 2008; ). Contribution of Panton-Valentineleukocidin in community-associated methicillin-resistant Staphylococcusaureus pathogenesis. PLoS One 3, e3198 [CrossRef]
    [Google Scholar]
  8. Dufour, P., Gillet, Y., Bes, M., Lina, G., Vandenesch, F., Floret,D., Etienne, J. & Richet, H. ( 2002; ). Community-acquiredmethicillin-resistant Staphylococcus aureus infection in France:emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35, 819–824.[CrossRef]
    [Google Scholar]
  9. Gillet, Y., Issartel, B., Vanhems, P., Fournet, J. C., Lina,G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N. & other authors ( 2002; ). Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethalnecrotising pneumonia in young immunocompetent patients. Lancet 359, 753–759.[CrossRef]
    [Google Scholar]
  10. Gorak, E. J., Yamada, S. M. & Brown, J. D. ( 1999; ). Community-acquired methicillin-resistant Staphylococcusaureus in hospitalized adults and children without known risk factors. Clin Infect Dis 29, 797–800.[CrossRef]
    [Google Scholar]
  11. HPA ( 2008; ). Guidance on the diagnosisand management of PVL-associated Staphylococcus aureus infections (PVL-SA)in England. Report prepared by the PVL sub-group of the Steering Group onHealthcare Associated Infection. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1218699411960.
  12. Jones, T. F., Creech, C. B., Erwin, P., Baird, S. G., Woron,A. M. & Schaffner, W. ( 2006; ). Family outbreaksof invasive community-associated methicillin-resistant Staphylococcusaureus infection. Clin Infect Dis 42, e76–e78.[CrossRef]
    [Google Scholar]
  13. Kluytmans, J., van Belkum, A. & Verbrugh, H. ( 1997; ). Nasal carriage of Staphylococcus aureus epidemiology,underlying mechanisms, and associated risks. Clin Microbiol Rev 10, 505–520.
    [Google Scholar]
  14. Kronvall, G., Karlsson, I., Walder, M., Sörberg, M. &Nilsson, L. E. ( 2006; ). Epidemiological MIC cut-offvalues for tigecycline calculated from Etest MIC values using normalized resistanceinterpretation. J Antimicrob Chemother 57, 498–505.[CrossRef]
    [Google Scholar]
  15. Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes,M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M. & otherauthors ( 2007; ). Staphylococcus aureus Panton-Valentineleukocidin causes necrotizing pneumonia. Science 315, 1130–1133.[CrossRef]
    [Google Scholar]
  16. Larsen, A. R., Stegger, M., Bocher, S., Sorum, M., Monnet, D.L. & Skov, R. L. ( 2009; ). Emergence and characterizationof community-associated methicillin-resistant Staphylococcus aureusinfections in Denmark 1999–2006. J Clin Microbiol 47, 73–78.[CrossRef]
    [Google Scholar]
  17. Naimi, T. S., Ledell, K. H., Como-Sabetti, K., Borchardt, S.M., Boxrud, D. J., Etienne, J., Johnson, S. K., Vandenesch, F., Fridkin, S. &other authors ( 2003; ). Comparison of community- andhealthcare- associated methicillin-resistant Staphylococcus aureusinfection. JAMA 290, 2976–2984.[CrossRef]
    [Google Scholar]
  18. Okuma, K., Iwakawa, K., Turnidge, J. D., Grubb, W. B., Bell,J. M., O'Brien, F. G., Coombs, G. W., Pearman, J. W., Tenover, F. C. &other authors ( 2002; ). Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40, 4289–4294.[CrossRef]
    [Google Scholar]
  19. Otter, J. A., Havill, N. L., Boyce, J. M. & French, G. L. ( 2009; ). Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA,2004–2006: where is USA300 in the UK? Eur J Clin MicrobiolInfect Dis 28, 835–839.
    [Google Scholar]
  20. Popovich, K. J. & Hota, B. ( 2008; ).Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. DermatolTher 21, 167–179.
    [Google Scholar]
  21. Rossney, A. S., Lawrence, M. J., Morgan, P. M., Fitzgibbon,M. M., Shore, A., Coleman, D. C., Keane, C. T. & O'Connell, B. ( 2006; ). Epidemiological typing of MRSA isolates from bloodcultures taken in Irish hospitals participating in the European AntimicrobialResistance Surveillance System (1999–2003). EurJ Clin Microbiol Infect Dis 25, 79–89.
    [Google Scholar]
  22. Rossney, A. S., Shore, A. C., Morgan, P. M., Fitzgibbon, M.M., O'Connell, B. & Coleman, D. C. ( 2007; ).The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harbouring the Panton-Valentineleukocidin gene (pvl) reveal that pvl is a poormarker for community-associated MRSA strains in Ireland. J ClinMicrobiol 45, 2554–2563.
    [Google Scholar]
  23. Salgado, C. D., Farr, B. M. & Calfee, D. P. ( 2003; ). Community-acquired methicillin-resistant Staphylococcusaureus: a meta-analysis of prevalence and risk factors. ClinInfect Dis 36, 131–139.
    [Google Scholar]
  24. Sdougkos, G., Chini, V., Papanastasiou, D. A., Christodoulou,G., Stamatakis, E., Vris, A., Christodoulidi, I., Protopapadakis, G. &Spiliopoulouet, I. ( 2008; ). Community-associated Staphylococcus aureus infections and nasal carriage among children: molecularmicrobial data and clinical characteristics. Clin Microbiol Infect 14, 995–1001.[CrossRef]
    [Google Scholar]
  25. Tseng, C. W., Kyme, P., Low, J., Rocha, M. A., Alsabeh, R.,Miller, L. G., Otto, M., Arditi, M., Diep, B. A. & other authors ( 2009; ). Staphylococcus aureus Panton-Valentine leukocidincontributes to inflammation and muscle tissue injury. PLoS One 4, e6387 [CrossRef]
    [Google Scholar]
  26. Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo,G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T. & other authors ( 2003; ). Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwideemergence. Emerg Infect Dis 9, 978–984.[CrossRef]
    [Google Scholar]
  27. Vourli, S., Vagiakou, H., Ganteris, G., Orfanidou, M., Polemis,M., Vatopoulos, A. & Malamou-Ladas, H. ( 2009; ).High rates of community-acquired, Panton-Valentine leukocidin (PVL)-positivemethicillin-resistant S. aureus (MRSA) infections in adultoutpatients in Greece. Euro Surveill 14.
    [Google Scholar]
  28. Weber, J. T. ( 2005; ). Community-associatedmethicillin-resistant Staphylococcus aureus. Clin InfectDis 41, S269–S272.
    [Google Scholar]
  29. Zafar, U., Johnson, L. B., Hanna, M., Riederer, K., Sharma,M., Fakih, M. G., Thirumoorthi, M. C., Farjo, R. & Khatib, R. ( 2007; ). Prevalence of nasal colonization among patients withcommunity-associated methicillin-resistant Staphylococcus aureusinfection and their household contacts. Infect Control Hosp Epidemiol 28, 966–999.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.015925-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error